Center for Translational Pediatric Research (CTPR)
转化儿科研究中心 (CTPR)
基本信息
- 批准号:9983103
- 负责人:
- 金额:$ 227.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-11 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:ArkansasBioinformaticsBrainCaringCell NucleusCellsCenters of Research ExcellenceChildChildhoodChronic Kidney FailureClinicalCore FacilityDevelopmentDevelopment PlansDevelopmental BiologyDiseaseEnsureEnvironmentEpigenetic ProcessEventExtramural ActivitiesFacultyFoundationsFundingFutureGastrointestinal tract structureGenomicsGoalsGrantGrowthHealthcareInstitutionInterdisciplinary StudyInternationalKnowledgeLongevityMalignant NeoplasmsMentorsMissionOutcomePancytopeniaPediatric HospitalsPediatric ResearchPediatricsPhasePilot ProjectsPopulationPositioning AttributeProteomicsResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch SupportResourcesScienceScientistSeedsSystems BiologyTeacher Professional DevelopmentTechnologyTranslatingTranslational ResearchUnited States National Institutes of Healthcancer imagingcareerexperiencefaculty researchimaging systemimprovedmembermultidisciplinarynew growthnext generationnovelprofessorprogramssuccesstargeted treatmenttherapy developmenttool
项目摘要
The Arkansas Children's Hospital Research Institute (ACHRI) proposes to establish a thematic, multidisciplinary research center titled the Center for Translational Pediatric Research (CTPR). ACHRI is located at Arkansas Children's Hospital, which is the only pediatric hospital in Arkansas; thus, providing a unique environment and clinical population to study pediatric diseases including cancer. Dr. Alan Tackett, a Professor of Pediatrics and an internationally recognized leader in the field of developmental epigenetics, cancer, systems biology and proteomics, will direct the center. He has extensive administrative experience and has mentored multiple junior faculty to the point of receiving their first R01s. NIH has continually funded Dr. Tackett, a native Arkansan, for his entire career, and he has been involved with the NIH IDeA program (through COBRE and INBRE grants) for over a decade. The scientific theme of the CTPR is the study of how pediatric diseases develop from systems biology and mechanistic standpoints with the ultimate goal of identifying intersections of disease and development, which, in turn, will produce targets for therapeutic intervention and the development of new treatments. The thematic focus of the CTPR is unique to COBRE-supported programs nation-wide. The centerpiece of the CTPR will be the use of state-of-the-art systems biology approaches to uncover and mechanistically explore the basis of pediatric diseases. The CTPR will have an Administrative Core, three Research Cores and four Research Projects. The Administrative Core will direct the activities of the center, establish and support Research Cores, oversee a Pilot Project Program and oversee mentoring of Project Leaders through a comprehensive Faculty Development Plan. The CTPR will support Proteomic, Genomic and Systems Biology Bioinformatics Research Cores, which are each essential for the thematic mission of the center. The center will initially invest in four junior faculty members all of whom will utilize systems biology tools to study a variety of pediatric conditions related to brain development, chronic kidney disease, gastrointestinal tract development, bone marrow failure, and cancer. The CTPR will truly be a thematic, multi-disciplinary center bringing together expertise in pediatric research, developmental biology, cancer, imaging, systems biology, bioinformatics, proteomics and genomics. The long-term goal of the CTPR is to provide longevity and sustainability for a thematic, multidisciplinary pediatric research center that utilizes cutting-edge systems biology technologies and state-of-the-art translational research to study pediatric diseases. The short- term goal for Phase I of the CTPR is to follow a Center Organization and Management Plan to establish the foundation of the center, develop and mentor junior investigators with a Faculty Development Plan, and grow the center members to a critical mass necessary to position the group to be competitive for extramural support beyond COBRE-funding.
阿肯色州儿童医院研究所 (ACHRI) 提议建立一个名为转化儿科研究中心 (CTPR) 的专题、多学科研究中心。 ACHRI 位于阿肯色州儿童医院,这是阿肯色州唯一的儿科医院;因此,为研究包括癌症在内的儿科疾病提供了独特的环境和临床人群。儿科教授、发育表观遗传学、癌症、系统生物学和蛋白质组学领域国际公认的领导者 Alan Tackett 博士将领导该中心。他拥有丰富的管理经验,并指导过多名初级教师,使他们获得了第一批 R01。 NIH 持续资助阿肯色人塔克特博士的整个职业生涯,十多年来他一直参与 NIH IDeA 项目(通过 COBRE 和 INBRE 资助)。 CTPR 的科学主题是从系统生物学和机制的角度研究儿科疾病如何发展,最终目标是确定疾病和发展的交叉点,进而为治疗干预和新疗法的开发提供目标。 CTPR 的主题重点是 COBRE 支持的全国性计划所独有的。 CTPR 的核心将是利用最先进的系统生物学方法来揭示和机械地探索儿科疾病的基础。 CTPR 将设有一个行政核心、三个研究核心和四个研究项目。行政核心将指导中心的活动,建立和支持研究核心,监督试点项目计划,并通过全面的教师发展计划监督对项目负责人的指导。 CTPR 将支持蛋白质组学、基因组学和系统生物学生物信息学研究核心,这些核心对于该中心的主题使命至关重要。该中心最初将投资四名初级教员,他们都将利用系统生物学工具来研究与大脑发育、慢性肾病、胃肠道发育、骨髓衰竭和癌症相关的各种儿科疾病。 CTPR 将真正成为一个专题、多学科中心,汇集了儿科研究、发育生物学、癌症、成像、系统生物学、生物信息学、蛋白质组学和基因组学方面的专业知识。 CTPR 的长期目标是为专题、多学科儿科研究中心提供长寿和可持续性,该中心利用尖端的系统生物学技术和最先进的转化研究来研究儿科疾病。 CTPR第一阶段的短期目标是遵循中心组织和管理计划,以建立中心的基础,通过教师发展计划培养和指导初级研究人员,并将中心成员发展到必要的临界数量。使该小组在获得 COBRE 资助之外的外部支持方面具有竞争力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan Tackett其他文献
Alan Tackett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan Tackett', 18)}}的其他基金
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10163815 - 财政年份:2019
- 资助金额:
$ 227.12万 - 项目类别:
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10630160 - 财政年份:2019
- 资助金额:
$ 227.12万 - 项目类别:
Identification of Druggable Targets to Complement Melanoma Therapy
确定可补充黑色素瘤治疗的药物靶点
- 批准号:
10412077 - 财政年份:2019
- 资助金额:
$ 227.12万 - 项目类别:
Center for Translational Pediatric Research (CTPR): Enhancing SARS-CoV-2 Sequencing Efforts for Variants in the State of Arkansas
转化儿科研究中心 (CTPR):加强阿肯色州 SARS-CoV-2 变异体的测序工作
- 批准号:
10595406 - 财政年份:2017
- 资助金额:
$ 227.12万 - 项目类别:
Center for Translational Pediatric Research (CTPR)
转化儿科研究中心 (CTPR)
- 批准号:
10380963 - 财政年份:2017
- 资助金额:
$ 227.12万 - 项目类别:
相似国自然基金
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Short Course: Integrative and Organ Systems Pharmacology
短期课程:综合和器官系统药理学
- 批准号:
7232109 - 财政年份:2005
- 资助金额:
$ 227.12万 - 项目类别:
Kansas IDeA Network of Biomedical Research Excellence (K-INBRE)
堪萨斯州 IDeA 生物医学研究卓越网络 (K-INBRE)
- 批准号:
10854513 - 财政年份:2001
- 资助金额:
$ 227.12万 - 项目类别:
Comparative Functional Genomics INBRE in Maine
比较功能基因组学 INBRE 缅因州
- 批准号:
8679216 - 财政年份:2001
- 资助金额:
$ 227.12万 - 项目类别:
Comparative Functional Genomics INBRE in Maine
比较功能基因组学 INBRE 缅因州
- 批准号:
9057564 - 财政年份:2001
- 资助金额:
$ 227.12万 - 项目类别:
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
综合癌症中心核心支持拨款
- 批准号:
10244595 - 财政年份:1997
- 资助金额:
$ 227.12万 - 项目类别: